# Extension Study to Gather Data on Effect of Macugen on the Corneal Endothelium

> **NCT01573572** · PHASE4 · COMPLETED · sponsor: **Bausch & Lomb Incorporated** · enrollment: 131 (actual)

## Conditions studied

- Age-Related Macular Degeneration
- Retinal Vein Occlusion
- Diabetic Macular Edema

## Interventions

- **DRUG:** pegaptanib sodium injection

## Key facts

- **NCT ID:** NCT01573572
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04-22
- **Primary completion:** 2019-11-14
- **Final completion:** 2019-11-14
- **Target enrollment:** 131 (ACTUAL)
- **Last updated:** 2021-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01573572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01573572, "Extension Study to Gather Data on Effect of Macugen on the Corneal Endothelium". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01573572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*